BE818990A - NEW PYRIMIDINES - Google Patents

NEW PYRIMIDINES

Info

Publication number
BE818990A
BE818990A BE147737A BE147737A BE818990A BE 818990 A BE818990 A BE 818990A BE 147737 A BE147737 A BE 147737A BE 147737 A BE147737 A BE 147737A BE 818990 A BE818990 A BE 818990A
Authority
BE
Belgium
Prior art keywords
new pyrimidines
pyrimidines
new
Prior art date
Application number
BE147737A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE818990A publication Critical patent/BE818990A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A63—SPORTS; GAMES; AMUSEMENTS
    • A63C—SKATES; SKIS; ROLLER SKATES; DESIGN OR LAYOUT OF COURTS, RINKS OR THE LIKE
    • A63C19/00—Design or layout of playing courts, rinks, bowling greens or areas for water-skiing; Covers therefor
    • A63C19/02—Shaping of the surface of courts according to the necessities of the different games
BE147737A 1973-08-20 1974-08-19 NEW PYRIMIDINES BE818990A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732341925 DE2341925A1 (en) 1973-08-20 1973-08-20 2,4, (opt.5-), 6-substd. pyriminidines as antithrombic agents - e.g. 6-methyl-5-nitro-2-piperazino-4-thiomorpolino-pyrimidine

Publications (1)

Publication Number Publication Date
BE818990A true BE818990A (en) 1975-02-19

Family

ID=5890167

Family Applications (1)

Application Number Title Priority Date Filing Date
BE147737A BE818990A (en) 1973-08-20 1974-08-19 NEW PYRIMIDINES

Country Status (4)

Country Link
JP (1) JPS5049288A (en)
BE (1) BE818990A (en)
DE (1) DE2341925A1 (en)
ZA (1) ZA745305B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075305A (en) * 1991-03-18 1991-12-24 Warner-Lambert Company Compound, composition and use
US5098902A (en) * 1991-03-18 1992-03-24 Warner-Lambert Company Method of treating neurodegenerative diseases

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1172255A (en) * 1980-12-11 1984-08-07 Robert R. Covington Buspirone process
JPH0635450B2 (en) * 1984-03-16 1994-05-11 三井東圧化学株式会社 Thiocyanopyrimidine derivative, its production method and agricultural / horticultural fungicide
US5658923A (en) * 1992-09-18 1997-08-19 Asahi Kasei Kogyo Kabushiki Kaisha Azepine derivatives and use thereof
EP0661271B1 (en) * 1992-09-18 2000-04-26 Asahi Kasei Kogyo Kabushiki Kaisha Azepine derivatives, production thereof, and use thereof as sigma-receptor ligands
CA2208900C (en) * 1996-07-18 2006-08-01 Lonza Ag Process for preparing 2-pyrimidinecarboxylates
DE69909756D1 (en) 1998-02-17 2003-08-28 Tularik Inc ANTIVIRAL PYRIMIDINE DERIVATIVES
US6410726B1 (en) 2000-01-12 2002-06-25 Tularik Inc. Arylsulfonic acid salts of pyrimidine-based antiviral
ATE527250T1 (en) 2002-11-21 2011-10-15 Novartis Ag 2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER
GEP20084540B (en) 2003-01-14 2008-11-25 Arena Pharm Inc 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
EP1927594A1 (en) * 2003-01-14 2008-06-04 Arena Pharmaceuticals, Inc. 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
RU2006102955A (en) 2003-07-02 2007-08-20 Вертекс Фармасьютикалз Инкорпорейтед (Us) PYRIMIDINES SUITABLE AS MODULATORS OF POTENTIAL DEPENDENT ION CHANNELS
AR045047A1 (en) 2003-07-11 2005-10-12 Arena Pharm Inc ARILO AND HETEROARILO DERIVATIVES TRISUSTITUIDOS AS MODULATORS OF METABOLISM AND PROFILAXIS AND TREATMENT OF DISORDERS RELATED TO THEMSELVES
JP4838128B2 (en) * 2003-07-30 2011-12-14 ゼノン・ファーマシューティカルズ・インコーポレイテッド Piperazine derivatives and their use as therapeutic agents
DK1648874T3 (en) 2003-07-30 2012-01-23 Xenon Pharmaceuticals Inc Piperazine derivatives as well as their use as therapeutically active substances
HUP0400405A3 (en) * 2004-02-10 2009-03-30 Sanofi Synthelabo Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates
JP2007217282A (en) * 2004-03-04 2007-08-30 Astellas Pharma Inc Substituted pyrimidine derivative
TW200624427A (en) 2004-09-20 2006-07-16 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
MX2007003321A (en) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents.
AU2005286728A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
CA2580855A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
TW200626592A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
US7592343B2 (en) 2004-09-20 2009-09-22 Xenon Pharmaceuticals Inc. Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors
CN101083992A (en) 2004-09-20 2007-12-05 泽农医药公司 Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
DOP2006000010A (en) 2005-01-10 2006-07-31 Arena Pharm Inc PROCEDURE TO PREPARE AROMATIC ETERES
WO2006130493A2 (en) 2005-05-31 2006-12-07 Vertex Pharmaceuticals Incorporated Heterocycles useful as modulators of ion channels
CA2618646A1 (en) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
GB0512844D0 (en) * 2005-06-23 2005-08-03 Novartis Ag Organic compounds
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي PI-3 Kinase inhibitors and methods of their use
ATE551334T1 (en) 2007-02-06 2012-04-15 Novartis Ag PI3-KINASE INHIBITORS AND METHODS OF USE THEREOF
NZ583495A (en) 2007-09-20 2011-11-25 Irm Llc Compounds and compositions as modulators of gpr119 activity
CA2720049A1 (en) * 2008-03-31 2009-10-08 Zenyaku Kogyo Kabushikikaisha Pyrimidine derivative having cell protecting effect and uses thereof
KR101687841B1 (en) * 2008-12-09 2016-12-19 길리애드 사이언시즈, 인코포레이티드 Modulators of toll-like receptors
CN103221410B (en) 2010-09-22 2017-09-15 艾尼纳制药公司 GPR119 receptor modulators and the treatment to relative obstacle
CA2849995A1 (en) 2011-09-27 2013-04-04 Novartis Ag 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
CN103204816B (en) 2012-01-16 2016-04-27 中国人民解放军军事医学科学院毒物药物研究所 Piperazinylpyrimidine analog derivative and its production and use
UY34632A (en) 2012-02-24 2013-05-31 Novartis Ag OXAZOLIDIN- 2- ONA COMPOUNDS AND USES OF THE SAME
US9296733B2 (en) 2012-11-12 2016-03-29 Novartis Ag Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
CN105263929B (en) 2013-03-14 2018-08-28 诺华股份有限公司 - oxazolidine -2- ketone compounds of 3- pyrimidine-4-yls as mutation IDH inhibitor
NZ734220A (en) 2015-01-06 2022-01-28 Arena Pharm Inc Methods of treating conditions related to the s1p1 receptor
IL285890B (en) 2015-06-22 2022-07-01 Arena Pharm Inc Crystalline free-plate habit of l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid
JP2020507611A (en) 2017-02-16 2020-03-12 アリーナ ファーマシューティカルズ， インコーポレイテッド Compounds and methods for the treatment of primary biliary cholangitis

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075305A (en) * 1991-03-18 1991-12-24 Warner-Lambert Company Compound, composition and use
US5098902A (en) * 1991-03-18 1992-03-24 Warner-Lambert Company Method of treating neurodegenerative diseases

Also Published As

Publication number Publication date
JPS5049288A (en) 1975-05-01
ZA745305B (en) 1976-04-28
DE2341925A1 (en) 1975-03-06

Similar Documents

Publication Publication Date Title
BE818990A (en) NEW PYRIMIDINES
ATA1011274A (en) EARSTUCK
AT325093B (en) FOOTLAY
AT359180B (en) OSTEOTOM
BE813158A (en) NEW BENZOQUINOLIZINES
FI56432B (en) GASKOLV I SKJUTVAPEN
BE814229A (en) NEW AZOLYLAMIDINS
BE813142A (en) NEW DISUBSTITLED PIPERAZINES
AT329420B (en) MONOSCHI
AT325408B (en) DADLESS
BE819773A (en) NEW BENZYLPYRIMIDINES
FR2295005A1 (en) NEW ODORING SUBSTANCES
DOP1974002166A (en) HETEROCYCLIC ANTILIDS
AT342382B (en) FLUXE
BE817294A (en) NEW SULFONYLOXYPHENYLUREES
BE813677A (en) NEW TRIAZOLO-1
AT354042B (en) RAFFSTORE
ATA280876A (en) FUGICIDE
BE793744A (en) GEWAPEND BOUWPANEEL
BE813947A (en) NEW DICHLOROTHIAZOLYLUREES
BE818131A (en) NEW BENZYLPYRIMIDINES
BE810364A (en) NEW BENZOYLPHENYLGUANIDINES
BE821477A (en) NEW PENICILLINS
IT1054123B (en) PYROSXIN PHOSPHOSERINATE
AT323390B (en) DOORSTOCK